Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2010
10/21/2010US20100267671 Compositions and methods for apoptosis modulators
10/21/2010US20100267668 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2
10/21/2010US20100266714 P2x3 receptor antagonists for treatment of pain
10/21/2010US20100266543 Linked dibenzimidazole antivirals
10/21/2010US20100266539 Chemokine receptor antagonist and medical use thereof
10/21/2010US20100266537 Hcv inhibitors
10/21/2010US20100266509 Heteroaryl amide analogues as p2x7 antagonists
10/21/2010US20100264370 Polymer comprising phenyl pyridine units
10/21/2010CA2758929A1 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2
10/21/2010CA2758918A1 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of ccr2
10/21/2010CA2758772A1 Indole derivative modulators of the alpha 7 nachr
10/21/2010CA2758484A1 Anti-viral compounds
10/20/2010EP2241564A1 3,8-diaminotetrahydroquinoline derivative
10/20/2010EP2241557A1 Chinoxalin derivatives and use thereof for treating malignant and benign tumour illnesses
10/20/2010EP2241555A1 New RAC1 inhibitors as potential pharmacological agents for heart failure treatment
10/20/2010EP2240496A2 Preparation of esomeprazole magnesium and hydrates thereof
10/20/2010EP2240468A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof
10/20/2010EP2240467A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
10/20/2010EP2240466A1 Pharmaceutically acceptable salts of 2-{4-[(3s)-piperidin-3- yl]phenyl} -2h-indazole-7-carboxamide
10/20/2010EP2240464A2 Process for preparation of 2-methyl-2´-phenylpropionic acid derivatives and novel intermediate compounds
10/20/2010EP2240463A2 2-methylene-(20s,25r)-19,26-dinor-vitamin d analogs
10/20/2010EP2240458A1 Aryl sulfonamides as effective analgesics
10/20/2010EP2240454A1 Mesoionic pesticides
10/20/2010EP2240453A1 Substituted-aryl-2-phenylethyl-1h-imidazole compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors
10/20/2010EP2240448A1 Lactam inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
10/20/2010EP2240441A1 Process for the preparation of 6-substituted-1-(2h)-isoquinolinones
10/20/2010EP2240178A1 Prolyl hydroxylase inhibitors
10/20/2010EP2240029A1 Compounds for inflammation and immune-related uses
10/20/2010EP2240026A1 NOVEL sEH INHIBITORS AND THEIR USE
10/20/2010EP2240021A1 Novel seh inhibitors and their use
10/20/2010EP2240016A1 Ampk modulators
10/20/2010EP2144897B1 8-oxy-quinoline derivatives as bradykinin b2 receptor modulators
10/20/2010EP1984331B1 Pyrrolidine derivatives as erk inhibitors
10/20/2010EP1899320B1 Substituted pyrr0lidin-2-0nes , piperidin-2-0nes and isothiazolidine-1, 1-dioxides, their use as kv1 .5 potassium channel blockers and pharmaceutical preparations comprising them
10/20/2010EP1899299B1 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
10/20/2010EP1811998B1 Triazoles useful as inhibitors of protein kinases
10/20/2010EP1722798B1 Pyrimidine compounds as purine receptor antagonists
10/20/2010EP1317431B1 Polyarylcarboxamides useful as lipid lowering agents
10/20/2010EP1308438B1 3-substituted urea derivatives and medicinal use thereof
10/20/2010EP0959075B1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
10/20/2010CN101868454A Cycloalkyloxy- and heterocycloalky-loxypyridine compounds as modulators of the histamine H3 receptor
10/20/2010CN101868453A Inhibitors of the interaction between MDM2 and P53
10/20/2010CN101868452A Spiropyrrolidines and their use against HCV and HIV infection
10/20/2010CN101868451A Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
10/20/2010CN101863883A Piperidone azine compound with activity of resisting leukemia K562 cell proliferation and preparation method thereof
10/20/2010CN101863880A Fasudil hydrochloride compound and novel method thereof
10/20/2010CN101863879A Preparation method of alpha crystalline azelnidipine
10/20/2010CN101863878A Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
10/20/2010CN101863877A Therapeutic agents useful for treating pain
10/20/2010CN101863876A Fluoroquinolone comprising 7-(3-amino-4-oximido)-1-piperidyl substitutional group and application of composition thereof
10/20/2010CN101863875A Triazole derivatives containing liquid crystal units and preparation method and application thereof
10/20/2010CN101863874A Pyrazole imine compound and application thereof
10/20/2010CN101863844A Synthesis method of 6,7-substituted-4-aniline quinazoline
10/20/2010CN101863839A N-3-aramid-5-cyclopropane spiro hydantoin derivative, preparation method and application thereof
10/20/2010CN101863824A Synthesis method of chemical compound containing a dihydrogen ferrocenylmethyl-substituted indenes ketone and pyrrole skeleton
10/20/2010CN101302194B Synthetic method of polysubstituted chinoline compound
10/19/2010US7816539 Melanocortin receptor MC4 modulators; obesity, sexual disorders, anxiolytic agents, analgesics, antidepressants; 6-(aminomethyl)-2-aminobenzimidazole derivatives
10/19/2010US7816534 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/19/2010US7816529 Sodium and calcium channel antagonists; higher potency; fewer side effects to central nervous system
10/19/2010US7816527 Quinazoline-containing kits for labeling aldehyde or ketone moieties
10/19/2010US7816521 1,2,4-benzotriazine-1,4-dioxides
10/19/2010US7816398 Fatty alcohol drug conjugates
10/19/2010US7816375 Ligands for monoamine receptors and transporters, and methods of use thereof
10/19/2010US7816369 Mediators of hedgehog signaling pathways, compositions and uses related thereto
10/19/2010US7816363 Inhibitors of histone deacetylase
10/19/2010US7816361 such as 4-(5-Oxo-3-pyrazin-2-yl-2,5-dihydro-pyrazol-1-yl)-N-(1,2,2,6,6-pentamethyl-piperidin-4-yl)-benzamide, used as immunomodulators for the treatment of rheumatoid arthritis, psoriasis, multiple sclerosis and diabetes
10/19/2010US7816360 MTP inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
10/19/2010US7816359 such as (4-[(4-methyl-1-piperazin-1-ylmethyl)-N-[4-methyl-3-[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide), used as antitumor agents
10/19/2010US7816357 Regulation of appetite, antiemetics, immunosuppression, analgesia, inflammation, antinocioception, sedation, and intraocular pressure; synergistic; 2-(4-(Trifluoromethyl)benzyl)-7,8-bis(4-chlorophenyl)-6-(methylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one
10/19/2010US7816349 (R)-3-{3,5-Dichloro-4'-[4-(2-fluoro-ethyl)-piperazine-1-carbonyl]-biphenyl-4-ylmethyl}-1-(4,4-difluoro-cyclohexyl)-pyrrolidin-2-one, used for the treatment of diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome and cognitive disorders
10/19/2010US7816348 2-amido-5-oxo/thio-benzoic acid derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons
10/19/2010US7816346 Benzoquinone imine-containing ansamycins and its acylation or alkylation derivatives; cellular proliferation, hyperproliferation; increase the bioavailability and reduce the toxicity associated with the natural product
10/19/2010US7816331 Substituted indazole-O-glucosides
10/19/2010CA2469346C Substituted 2-pyrrolidin-2-yl-1h-indole derivatives for treatment of migraine
10/19/2010CA2464367C Bicyclic compounds
10/19/2010CA2463284C Pyrimidine compounds and pharmaceutical compositions containing the compounds
10/19/2010CA2393158C Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
10/19/2010CA2362715C Quinazoline derivatives as angiogenesis inhibitors
10/14/2010WO2010118063A2 Therapeutic compositions and related methods of use
10/14/2010WO2010118015A1 Control of concentric tubing direction
10/14/2010WO2010117979A2 Serotonin and norepinephrine reuptake inhibitor
10/14/2010WO2010117932A1 Indole derivatives and methods for antiviral treatment
10/14/2010WO2010117756A2 Substituted benzimidazole pharmaceutical formulations
10/14/2010WO2010117090A1 Novel isoquinolinyloxymethyl heteroaryl derivatives
10/14/2010WO2010117085A1 Aryl indole derivatives
10/14/2010WO2010117084A1 Novel isoquinoline derivatives
10/14/2010WO2010117040A1 Five-membered heterocyclic compound
10/14/2010WO2010117014A1 Triazine derivative
10/14/2010WO2010116915A1 Cyclic compound having substituted phenyl group
10/14/2010WO2010116740A1 Pyridine thio derivative, and pharmaceutical composition which contains same and has anti-helicobacter pylori action
10/14/2010WO2010116282A1 4, 5-dihydro-lh-pyrazole compounds and their pharmaceutical uses
10/14/2010WO2010116248A1 Organic compounds and their uses
10/14/2010WO2010115981A1 7-azadispiro [3.0.4.1] decane-8-carboxamides as hepatitis c virus inhibitors
10/14/2010WO2010115836A1 Substituted piperidines as ccr3 antagonists
10/14/2010WO2010115736A2 Dihydroorotate dehydrogenase inhibitors
10/14/2010WO2010115719A1 Quinoxaline derivatives and their use for treating benign and malignant tumour disorders
10/14/2010WO2010115688A1 Anthelmintic agents and their use
10/14/2010WO2010115548A1 Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof
10/14/2010WO2010115491A2 Piperidine and piperazine derivatives as autotaxin inhibitors
10/14/2010WO2010115279A1 Kinase inhibitors and method of treating cancer with same
1 ... 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 ... 1080